Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Oncol Lett. 2020 Feb;19(2):1317-1321. doi: 10.3892/ol.2019.11225. Epub 2019 Dec 18.

2.

A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

Chiba S, Ohue M, Gryniukova A, Borysko P, Zozulya S, Yasuo N, Yoshino R, Ikeda K, Shin WH, Kihara D, Iwadate M, Umeyama H, Ichikawa T, Teramoto R, Hsin KY, Gupta V, Kitano H, Sakamoto M, Higuchi A, Miura N, Yura K, Mochizuki M, Ramakrishnan C, Thangakani AM, Velmurugan D, Gromiha MM, Nakane I, Uchida N, Hakariya H, Tan M, Nakamura HK, Suzuki SD, Ito T, Kawatani M, Kudoh K, Takashina S, Yamamoto KZ, Moriwaki Y, Oda K, Kobayashi D, Okuno T, Minami S, Chikenji G, Prathipati P, Nagao C, Mohsen A, Ito M, Mizuguchi K, Honma T, Ishida T, Hirokawa T, Akiyama Y, Sekijima M.

Sci Rep. 2019 Dec 20;9(1):19585. doi: 10.1038/s41598-019-55069-y.

3.

Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Mol Clin Oncol. 2019 Dec;11(6):557-562. doi: 10.3892/mco.2019.1930. Epub 2019 Oct 3.

4.

Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.

Nomura S, Konishi A, Tsubokura Y, Azuma Y, Hotta M, Yoshimura H, Nakanishi T, Fujita S, Satake A, Katayama Y, Ohta S, Hayashi K, Ishii K, Ito T.

Transpl Immunol. 2019 Dec;57:101247. doi: 10.1016/j.trim.2019.101247. Epub 2019 Oct 27.

PMID:
31666188
5.

ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma.

Iwata R, Hyoung Lee J, Hayashi M, Dianzani U, Ofune K, Maruyama M, Oe S, Ito T, Hashiba T, Yoshimura K, Nonaka M, Nakano Y, Norian L, Nakano I, Asai A.

Neuro Oncol. 2020 Mar 5;22(3):333-344. doi: 10.1093/neuonc/noz204.

PMID:
31634400
6.

A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms.

Nakanishi T, Nakaya A, Nishio Y, Fujita S, Satake A, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Kadosaka Y, Ishii K, Ito T, Tsuta K, Nomura S.

Hematol Rep. 2019 Sep 18;11(3):7971. doi: 10.4081/hr.2019.7971. eCollection 2019 Sep 18.

7.

The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells.

Kibata K, Ito T, Inaba M, Tanaka A, Iwata R, Inagaki-Katashiba N, Phan V, Satake A, Nomura S.

J Blood Med. 2019 Jul 12;10:217-226. doi: 10.2147/JBM.S206459. eCollection 2019.

8.

Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression.

Inagaki-Katashiba N, Ito T, Inaba M, Azuma Y, Tanaka A, Phan V, Kibata K, Satake A, Nomura S.

Eur J Immunol. 2019 Nov;49(11):2051-2062. doi: 10.1002/eji.201847992. Epub 2019 Jul 11.

9.

Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 May 25;12:100174. doi: 10.1016/j.lrr.2019.100174. eCollection 2019. No abstract available.

10.

Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma.

Azuma Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 May 25;12:100173. doi: 10.1016/j.lrr.2019.100173. eCollection 2019.

11.

Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.

Ito T, Hashimoto Y, Tanaka Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Konishi A, Hotta M, Yoshimura H, Ishii K, Hashimoto A, Kondo T, Omura H, Shinzato I, Tanaka T, Nomura S.

Eur J Haematol. 2019 Aug;103(2):116-123. doi: 10.1111/ejh.13265. Epub 2019 Jun 17.

12.

Evaluation of eltrombopag in patients with aplastic anemia in real-world experience.

Konishi A, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Leuk Res Rep. 2019 Mar 5;11:11-13. doi: 10.1016/j.lrr.2019.03.002. eCollection 2019.

13.

Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia.

Ishii K, Nakaya A, Fujita S, Satake A, Azuma Y, Tsubokura Y, Saito R, Konishi A, Hotta M, Yoshimura H, Ito T, Nomura S.

Leuk Res Rep. 2019 Mar 5;11:8-10. doi: 10.1016/j.lrr.2019.03.001. eCollection 2019.

15.

Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.

Nomura S, Ito T, Katayama Y, Ota S, Hayashi K, Fujita S, Satake A, Ishii K.

Transpl Immunol. 2019 Apr;53:28-33. doi: 10.1016/j.trim.2018.12.001. Epub 2018 Dec 10.

PMID:
30543860
16.

GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.

Hotta M, Yoshimura H, Satake A, Tsubokura Y, Ito T, Nomura S.

Eur J Immunol. 2019 Jan;49(1):179-191. doi: 10.1002/eji.201847684. Epub 2018 Dec 4.

17.

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Hematol Rep. 2018 Sep 5;10(3):7474. doi: 10.4081/hr.2018.7474. eCollection 2018 Sep 5.

18.

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).

Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T.

Vasc Health Risk Manag. 2018 Sep 18;14:225-232. doi: 10.2147/VHRM.S171143. eCollection 2018.

19.

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.

Ito T, Konishi A, Tsubokura Y, Azuma Y, Hotta M, Yoshimura H, Nakanishi T, Fujita S, Nakaya A, Satake A, Ishii K, Nomura S.

Front Nutr. 2018 Aug 21;5:72. doi: 10.3389/fnut.2018.00072. eCollection 2018.

20.

[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].

Ishii K, Azuma Y, Konishi A, Tsubokura Y, Yoshimura H, Hotta M, Nakanishi T, Nakaya A, Fujita S, Satake A, Miyaji M, Ito T, Nomura S.

Rinsho Ketsueki. 2018;59(8):1002-1006. doi: 10.11406/rinketsu.59.1002. Japanese.

PMID:
30185698

Supplemental Content

Loading ...
Support Center